Pediatric Nephrology

, Volume 29, Issue 3, pp 343-351

First online:

The bioartificial kidney: current status and future promise

  • H. David HumesAffiliated withInnovative BioTherapies, Inc.Department of Internal Medicine, University of Michigan Medical SchoolCytoPherx, Inc.Internal Medicine, Division of Nephrology, University of Michigan Email author 
  • , Deborah BuffingtonAffiliated withInnovative BioTherapies, Inc.
  • , Angela J. WestoverAffiliated withInnovative BioTherapies, Inc.
  • , Shuvo RoyAffiliated withDepartment of Bioengineering & Therapeutic Sciences, University of California, San Francisco
  • , William H. FissellAffiliated withDepartment of Nephrology and Hypertension, Vanderbilt University Medical Center

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


The rapid understanding of the cellular and molecular bases of organ function and disease processes will be translated in the next decade into new therapeutic approaches to a wide range of clinical disorders, including acute and chronic renal failure. Central to these new therapies are the developing technologies of cell therapy and tissue engineering, which are based on the ability to expand stem or progenitor cells in tissue culture to perform differentiated tasks and to introduce these cells into the patient either via extracorporeal circuits or as implantable constructs. Cell therapy devices are currently being developed to replace the filtrative, metabolic, and endocrinologic functions of the kidney lost in both acute and chronic renal failure. This review summarizes the current state of development of a wearable or implantable bioartificial kidney. These devices have the promise to be combined to produce a wearable or implantable bioartificial kidney for full renal replacement therapy that may significantly diminish morbidity and mortality in patients with acute or chronic kidney disease.


Extracorporeal cell therapy Tissue engineering Progenitor cells Acute renal failure End-stage renal disease